Recent Updates
Recently added Catalysts
ICLR Positive Sentiment Score: 70/100

ICON plc Schedules Third Quarter 2023 Earnings Conference Call DUBLIN--(BUSINESS WIRE)

Key Takeaway: ICON plc has announced the schedule for its third quarter 2023 earnings conference call, which is set to take place on October 26, 2023. The company will release its financial results after the market closes on October 25, 2023. Participants can access the live webcast through the Investor section of ICON's website. The announcement also highlights various forward-looking statements, reminding investors of potential risks and uncertainties that may affect the company's performance.

Market Sentiment Analysis

POSITIVE FACTORS

  • ICON plc is a leading healthcare intelligence and clinical research organization.
  • The upcoming earnings call indicates strong communication and transparency with investors.
  • The company is expanding its services and is involved in advancing clinical research.
  • ICON operates in a global market with a significant workforce, indicating growth potential.

CONCERNS & RISKS

  • Forward-looking statements are subject to various uncertainties and risks.
  • Potential impacts of COVID-19 on business are mentioned as a risk factor.
  • There are challenges related to maintaining client relationships and integrating new mergers.

Full Press Release Details

ICON plc Schedules Third Quarter 2023 Earnings Conference Call

DUBLIN--(BUSINESS WIRE)--September 21, 2023--ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that it will release its financial results for the third quarter 2023
after the market closes on Wednesday, October 25, 2023. The company will hold a conference call and webcast to discuss its financial results and performance on Thursday, October 26, 2023 at 8:00am ET.
Any changes to these events and links to the live webcasts (where available) will be posted on the Investor section of our website under "Events". A webcast replay of the conference call will be available approximately one hour following the
conclusion of the call.
ICON plc is a world-leading healthcare intelligence and clinical research organization. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and
public health organizations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in Dublin, Ireland, ICON employed approximately 41,160 employees in 108 locations in 53 countries as at June
30, 2023. For further information about ICON, visit: www.iconplc.com.
This press release contains forward-looking statements. These statements are based on management's current expectations and information currently available, including current economic and industry conditions. These statements are not
guarantees of future performance or actual results, and actual results, developments and business decisions may differ from those stated in this press release. The forward-looking statements are subject to future events, risks, uncertainties
and other factors that could cause actual results to differ materially from those projected in the statements, including, but not limited to, the ability to enter into new contracts, maintain client relationships, manage the opening of new
offices and offering of new services, the integration of new business mergers and acquisitions, the impact of COVID-19 on our business, as well as other economic and global market conditions and other risks and uncertainties detailed from time
to time in SEC reports filed by ICON, all of which are difficult to predict and some of which are beyond our control. For these reasons, you should not place undue reliance on these forward-looking statements when making investment decisions.
The word "expected" and variations of such words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are only as of the date they are made and we do not undertake any obligation to update
publicly any forward-looking statement, either as a result of new information, future events or otherwise. More information about the risks and uncertainties relating to these forward-looking statements may be found in SEC reports filed by
ICON, including its Form 20-F, F-1, F-4, S-8, F-3 and certain other reports, which are available on the SEC's website at http://www.sec.gov.

Contacts

Vice President Investor Relations

Frequently Asked Questions

When will ICON plc release its Q3 2023 financial results?

ICON plc will release its Q3 2023 financial results on October 25, 2023.

What time is ICON’s Q3 earnings conference call scheduled?

The conference call is set for October 26, 2023, at 8:00 am ET.

Where can I find links to ICON's webcast?

Links to the webcast will be available in the Investor section of ICON's website.

How many employees does ICON plc have?

As of June 30, 2023, ICON employed approximately 41,160 people.

What does ICON plc specialize in?

ICON plc specializes in healthcare intelligence and clinical research services.

Last updated: Sep 21, 2023